Jaguar inks deal with Glenmark to produce animal diarrhea drugs – FiercePharma Manufacturing


Jaguar inks deal with Glenmark to produce animal diarrhea drugs
FiercePharma Manufacturing
Jaguar Animal Health ($ JAGX) has inked a four-year deal with India's Glenmark Pharmaceuticals to manufacture and supply crofelemer for use in treating diarrhea in pets. Crofelemer is the API in Jaguar's lead prescription drug Canalevia, which is

and more »

diarrhea – Google News